|Articles|January 1, 2002

Symposium Reporter - Lipid Management
Volume 8
Issue 1 Symp

Risk Factors Common to Insulin Resistance and Atherosclerosis Explain Why Diabetes is a Cardiovascular Disease

Download PDF: Risk Factors Common to Insulin Resistance and Atherosclerosis Explain Why Diabetes is a Cardiovascular Disease

Articles in this issue

about 24 years ago

Article

Cholesterol Goals Established for Patients with Diabetes and Metabolic Syndrome

about 24 years ago

Article

Dyslipidemia of Insulin Resistance Syndrome Explained; Need for Treatment to Reduce Risk Emphasized

about 24 years ago

Article

Review of Clinical trial Data Reaffirms Safety of Statin Therapy

about 24 years ago

Article

Protective Effects of HDL-C and Need to Raise Low Levels Explored

about 24 years ago

Article

Question and Answer

about 24 years ago

Article

Heart Protection Study Finds Simvastatin Reduces Vascular Risk in a Wide Range of High-Risk Patients

about 24 years ago

Article

Lipid-Lowering Therapy Stabilizes Plaque Reduces Events by Limiting Inflammation

about 24 years ago

Article

New Cholesterol Guidelines Emphasize Risk Assessment

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

ByNate C. Apathy, PhD

January 27th 2026

Building Trust: Public Priorities for Health Care AI Labeling

ByMorgan L. Sielaff, BS,Jodyn Platt, PhD, MPH,Sean Tan, MPP,Kerry A. Ryan, MA,Paige Nong, PhD,Sharon L. R. Kardia, PhD

January 27th 2026

Ambient AI Tool Adoption in US Hospitals and Associated Factors

ByFreddie Yang, MA,Ilana Graetz, PhD

January 27th 2026

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Risk Factors Common to Insulin Resistance and Atherosclerosis Explain Why Diabetes is a Cardiovascular Disease

Articles in this issue

Newsletter

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Specialty and Operator Status Influence Electronic Health Record Use Variation

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule

Photobiomodulation, Bio-Machines, and the Future of Dermatology

The Strategic Necessity of Pharma-MedTech Convergence in an Era of Precision Medicine

Combination Therapy, Biologics, and Surgery Redefine HS Care in 2026

Tildrakizumab Shows Long-Term Psoriasis Control for Hard-to-Treat Areas